drugset / Trial / NCT03394989
BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to demonstrate the pharmacodynamic bioequivalence of the test product to the reference product in adult patients with asthma.
Timeline
- Start
- 2018-10-17
- Primary completion
- 2019-12-03
- Completion
- 2020-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone propionate | Other / unclassified | 100 ug | Inhaled |
| Subject | Salmeterol | Other / unclassified | 50 ug | Inhaled |